Can Stepan (SCL) Trade At A Discount Without Looking Cheap?
Stepan (SCL) stock has seen a recovery over the past year, but still faces a significant five-year decline. The current valuation, based on Simply Wall St's checks, suggests the shares are neither obviously cheap nor expensive, trading close to their fair P/S value of 0.6x. Future performance will depend on the company's ability to convert revenue into cash flow and maintain margins, making its current middling valuation a point of interest for value-oriented investors.
Stepan Number of Employees 2026 | Employee Count & Headcount Data
Stepan Co. (SCL) had approximately 2,301 employees worldwide as of March 2026, marking a 3.8% decline since 2023. The company, headquartered in Northbrook, Illinois, is actively hiring but has seen a significant 60.9% decrease in active job postings from 2025 to 2026. North America holds the largest concentration of its workforce, and the average salary globally is $74,689.
Empowered Funds LLC Raises Stake in Stepan Company $SCL
Empowered Funds LLC significantly increased its stake in Stepan Company (NYSE:SCL) by 124.8% in the first quarter, now owning 174,376 shares valued at $8.7 million. This move is part of broader institutional interest, with hedge funds and institutional investors collectively holding 82.70% of the company's stock. Stepan recently reported strong quarterly earnings, beating analyst estimates with an EPS of $1.18 and a 15% year-over-year revenue increase, alongside declaring a quarterly dividend of $0.395 per share.
Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts
Stepan Company exceeded analyst expectations in its second-quarter results, with revenues 7.6% above estimates and statutory earnings per share 133% ahead. Despite this, analysts are now forecasting a loss for 2026, a dip in sentiment from previous profit predictions, though the average price target increased by 13%. The company is projected to grow faster than the broader industry, with an 8.3% annualised revenue growth forecast until the end of 2026, significantly better than its 1.5% annual decline over the past five years.
Stepan Co (SCL) CFO settles RSUs into stock, withholds shares for taxes
Stepan Co's CFO, Ruben Dario Velasquez, settled 1,358 Restricted Stock Units (RSUs) into common stock at $64.675 per share on August 10, 2026. A total of 398 shares were withheld for tax liabilities, leaving 2,716 RSUs outstanding which will vest ratably over three years. This transaction was part of his equity compensation, and no Rule 10b5-1 trading plan was indicated.
Stronger Q2 Earnings And Maintained Dividend Might Change The Case For Investing In Stepan (SCL)
Stepan Company reported stronger Q2 2026 earnings with sales of US$684.11 million and net income of US$22.91 million, a positive shift despite a six-month net loss of US$18.50 million. The company maintained its quarterly dividend of US$0.395 per share, indicating a focus on shareholder returns amidst profitability and cash flow challenges. This mixed financial picture suggests investors should weigh the earnings rebound against ongoing cash flow risks when evaluating Stepan's investment prospects.
Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts
Stepan Company (NYSE:SCL) exceeded Q2 revenue and EPS forecasts, reporting US$684m in revenue (7.6% above estimates) and US$1.00 EPS (133% above expectations). Analysts now predict revenues of US$2.53b for 2026, an improvement of 4.1% over the last 12 months, though they anticipate a loss of US$0.16 per share, a shift from previous profit forecasts. Despite the projected loss, the average price target rose 13% to 75, and Stepan is expected to grow faster than the industry average.
Wall Street Zen Upgrades Stepan (NYSE:SCL) to Buy
Wall Street Zen has upgraded Stepan (NYSE:SCL) from "hold" to "buy," despite MarketBeat's overall analyst consensus remaining "Reduce." This upgrade follows Stepan's strong quarterly earnings, where it surpassed EPS and revenue expectations, leading to a 1.8% rise in shares to $65.14. Institutional investors hold a significant 82.7% of the stock, with several major investors recently increasing their positions.
Stepan (SCL) After Q2 Results Has A Valuation Question Worth Watching
Stepan (SCL) recently reported Q2 2026 results with strong sales and net income, alongside affirming its quarterly dividend. The stock has shown recent momentum with a 13.18% 30-day return, though its 3-year total shareholder return is down. Despite a P/S ratio suggesting fair valuation compared to peers, a Discounted Cash Flow model indicates significant undervaluation.
Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts
Stepan Company (NYSE:SCL) exceeded Q2 revenue and EPS expectations, reporting US$684m and US$1.00 respectively, significantly above analyst estimates. Despite the strong Q2 performance, analysts are now forecasting a loss for 2026, though the average price target increased, suggesting these losses might be temporary. The company is expected to outpace industry revenue growth, projected at 8.3% annually compared to the industry's 4.8%.
Stepan (SCL) After Q2 Results Has A Valuation Question Worth Watching
Stepan (SCL) recently reported Q2 2026 results with sales of US$684.11 million and net income of US$22.91 million, affirming a quarterly dividend. While the stock has seen recent momentum, its 3-year return is still down. The article explores Stepan's valuation, noting its 0.6x Price-to-Sales multiple is undervalued compared to peers and the industry, yet a Discounted Cash Flow model suggests an even larger undervaluation.
Stepan Company $SCL Shares Sold by Public Employees Retirement System of Ohio
Public Employees Retirement System of Ohio significantly reduced its stake in Stepan Company (NYSE: SCL) by 94.1% in the first quarter, selling over 27,000 shares. Despite this, institutional investors and hedge funds still own 82.7% of the company. Stepan reported strong quarterly earnings, beating estimates with a 15% revenue increase year-over-year, and declared a quarterly dividend of $0.395 per share.
Stepan (SCL) Posts Stronger Q2 Results And Affirms Dividend, Does The Stock Still Look Cheap?
Stepan (SCL) reported strong Q2 results, affirmed its dividend, and announced governance changes, leading to significant share price momentum. Despite recent gains and a period of unprofitability, the stock appears undervalued with a Price-to-Sales (P/S) ratio of 0.6x, compared to a fair P/S of 0.6x and higher industry averages. Both P/S analysis and a Discounted Cash Flow model suggest the stock is trading below its estimated fair value, but risks related to net losses and past shareholder returns remain.
How Stepan Company (SCL) Affects Rotational Strategy Timing
This article analyzes Stepan Company (SCL) and its impact on rotational trading strategies using AI models. It highlights weak near-term sentiment but potential long-term upside, providing specific institutional trading strategies including position, momentum breakout, and risk hedging with entry, target, and stop loss points. The analysis also includes multi-timeframe signal strengths and support/resistance levels for various holding periods.
How Stepan Company (SCL) Affects Rotational Strategy Timing
This article analyzes Stepan Company (SCL) and its impact on rotational trading strategies using AI models. It identifies weak near-term sentiment for SCL but strong mid- and long-term outlooks, with no resistance levels above the current price. The article details three institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) and provides multi-timeframe signal analysis, including support and resistance levels.
Does Stepan (SCL) Balancing Quarterly Profits and Dividends Clarify Its Long‑Term Strategy?
Stepan Company reported mixed financial results with stronger second-quarter earnings but a net loss for the first half of 2026. Despite this, the company reaffirmed its quarterly dividend, signaling a focus on capital returns. Analysts project significant revenue and earnings growth by 2029, suggesting a potential 17% upside to its current price.
STEPAN CO Q2 2026: Revenue $684.1M, EPS $1— 10-Q Summary
Stepan Co (SCL) reported strong second-quarter 2026 results, with revenue reaching $684.1 million and diluted earnings per share at $1.00. This performance was driven by a 15% year-over-year increase in revenue and a doubling of net income, primarily due to higher selling prices and improved product mix, especially in surfactants. The company also initiated "Project Catalyst" to improve operational efficiency and reduce costs.
Stepan (NYSE: SCL) VP Eaken reports direct and ESOP-held share ownership
Matthew John Eaken, VP, Controller & PAO of Stepan Company (NYSE: SCL), filed an initial statement of beneficial ownership. The report details his direct ownership of 9,319 common shares and indirect ownership of 3,102 shares through an ESOP II Trust. Additionally, the filing outlines his holdings in stock options, stock appreciation rights, performance shares, and restricted stock units, all tied to Stepan common stock with various vesting conditions and exercise prices.
Stepan Company $SCL Shares Bought by Sei Investments Co.
Sei Investments Co. significantly increased its stake in Stepan Company (NYSE:SCL) by 465.5% in the first quarter, now owning 123,800 shares valued at approximately $6.19 million. Stepan recently reported strong quarterly earnings, beating analyst expectations with an EPS of $1.18 and a 15% year-over-year revenue increase to $684.1 million. Despite this, analysts maintain a cautious "Reduce" consensus rating for the stock.
Does Stepan (SCL) Balancing Quarterly Profits and Dividends Clarify Its Long‑Term Strategy?
Stepan Company reported mixed Q2 2026 results, with stronger quarterly earnings but a six-month net loss of US$18.5 million. The company affirmed its quarterly dividend of US$0.395 per share, highlighting a focus on capital returns despite the year-to-date loss. Investors are watching for earnings normalization and improved cash flow, with revenue projected to reach US$2.8 billion and earnings US$137.8 million by 2029, suggesting a potential 17% upside to its current price.
Does Stepan (SCL) Balancing Quarterly Profits and Dividends Clarify Its Long‑Term Strategy?
Stepan Company reported mixed Q2 2026 results with stronger quarterly earnings but a six-month net loss, while affirming its quarterly dividend. This situation highlights the company's focus on capital returns amidst efforts to normalize earnings and manage costs, particularly regarding margin pressures in its Surfactants and Polymers segments. Investors are encouraged to consider diverse fair value estimates and a detailed analysis of the company's financial health to form their own investment verdicts.
Stepan (SCL) Stock Cools Even As Margin Repair Gains Force
Stepan (SCL) stock dropped 1.6% despite Q2 earnings showing significant margin repair with adjusted EBITDA rising to US$74.4m, an increase of about 45% year-over-year. Net sales reached US$684.1m, and adjusted EPS hit US$1.18, indicating a strong rebound in profitability. The market's reaction suggests focus on a modest pullback after a strong run, viewing the quarter as tidy rather than a full sentiment reset, while analysts note ongoing efforts from Project Catalyst and operational improvements.
Stepan Releases Q2 2026 Financial Results
Stepan Company reported strong Q2 2026 financial results, significantly exceeding Wall Street's earnings expectations. The company posted adjusted earnings of $1.18 per share, beating the consensus estimate by 90.3%, with revenue climbing to $684.1 million, an increase of 15.0% year-over-year. Surfactants were a key growth driver, and analysts maintain a positive outlook on the stock.
Stepan Declares Quarterly Dividend
Stepan Company (NYSE: SCL) has announced a quarterly cash dividend of $0.395 per share, payable on September 15, 2026, to stockholders of record on September 1, 2026. This marks the 58th consecutive year the company has increased its cash dividend. Stepan is a major manufacturer of specialty and intermediate chemicals, including surfactants and polyurethane polyols.
Stepan Releases Q2 2026 Financial Results
Stepan Company exceeded Wall Street expectations in Q2 2026, reporting adjusted earnings of $1.18 per share, significantly beating the $0.62 consensus. The specialty chemicals manufacturer saw revenue climb to $684.1M, a 15.0% increase year-over-year, driven by strong organic sales volume growth of 6.0% and strong performance in its surfactants division. Analysts maintain a positive stance on the stock, reflecting improved margins and operational execution.
Earnings Flash (SCL) Stepan Company Posts Q2 Adjusted EPS $1.18 per Share, Vs. FactSet Est of $0.61
Stepan Company (SCL) reported strong Q2 adjusted earnings per share of $1.18, significantly exceeding the FactSet estimate of $0.61. This indicates a robust financial performance by the company during the second quarter.
Stepan Co. (SCL) Surpasses Q2 Earnings and Revenue Estimates
Stepan Co. (SCL) reported strong Q2 results, with earnings of $1.18 per share against an estimate of $0.61, representing a +93.44% surprise. The company also surpassed revenue estimates, posting $684.11 million compared to a $594.69 million year-ago figure. While SCL shares have gained significantly year-to-date, their immediate future performance will largely depend on the management's outlook during the earnings call, with the stock currently holding a Zacks Rank #3 (Hold).
Stepan Company Q2 net income doubles on volume growth and margin recovery, plans workforce cuts.
Stepan Company reported a 102% increase in Q2 2026 net income to $22.9 million, driven by higher sales volumes, margin recovery, and efficiency gains. Adjusted EBITDA rose 45% year-over-year to $74.4 million, with strong growth in Surfactants and Polymers. The company also announced plans to reduce its global salaried workforce by approximately 100 positions as part of ongoing restructuring efforts.
Stepan Declares Quarterly Dividend
Stepan Company has announced a quarterly cash dividend of $0.395 per share, payable on September 15, 2026, to stockholders of record on September 1, 2026. This marks the 58th consecutive year the company has increased its cash dividend, following a $0.010 per share increase in Q4 2025. Stepan is a major manufacturer of specialty and intermediate chemicals, including surfactants and polyurethane polyols, used across various industries globally.
Stepan's Cash Dividend Streak Reaches 58 Consecutive Years
Stepan Company (NYSE: SCL) has declared a quarterly cash dividend of $0.395 per share, payable on September 15, 2026, to shareholders of record as of September 1, 2026. This dividend marks the 58th consecutive year of dividend increases for the specialty and intermediate chemical manufacturer, a streak maintained by a $0.010 per share raise in the fourth quarter of 2025. The company emphasizes its role as a major global producer of surfactants and polyurethane polyols.
Stepan faces earnings test as restructuring plan unfolds By Investing.com
Stepan Company is set to release its second-quarter earnings, with analysts anticipating improved profitability driven by a cost-reduction program called Project Catalyst. Investors will be closely watching the progress of this restructuring plan, margin trends, and volume momentum across end markets. Despite a turbulent first quarter with a net loss due to restructuring charges, the company expects its efficiency plan to counteract margin pressures.
Stepan faces earnings test as restructuring plan unfolds By Investing.com
Stepan Company is set to report second-quarter earnings, with analysts anticipating improved profitability driven by a restructuring plan, Project Catalyst. Investors will focus on the progress of this cost-reduction initiative, margin trends indicating a shift to higher-value products, and volume momentum across end markets. The company's stock is priced for a turnaround, contingent on the successful execution and impact of its restructuring efforts.
Stepan Co (SCL) Valuation: PE, PB & Fair Value Analysis
Stepan Co (SCL) currently holds a valuation score of 8.90, ranking 16th out of 65 companies in the Chemicals industry. Its P/E ratio is -92.70, which is significantly below its recent high and slightly above its recent low. Other key valuation metrics like P/B, P/S, and P/CF have not yet been disclosed by the company.
SCL|Stepan Co|Price:57.500|Chg%:-0.070
This article provides a comprehensive stock analysis of Stepan Co (SCL) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation, ranking 12th in the Chemicals industry. Despite positive analyst ratings and institutional confidence, technical indicators suggest sideways trading. The analysis covers the company's financial health, valuation, earnings forecasts, price momentum, institutional confidence, and risk assessment, explaining how each score is generated.
Stepan Co (SCL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a brief overview of Stepan Co (SCL)'s stock performance and a breakdown of its revenue by geographic region. The company's market capitalization is $1.30 billion, and its stock price is $57.570. The regional revenue data indicates that the United States contributes the largest proportion of revenue for Stepan Co, followed by France and other countries.
SCL|Stepan Co|Price:57.570|Chg%:+0.050
Stepan Co (SCL) is trading at $57.570 with a slight increase of 0.09%. The company, a manufacturer of specialty and intermediate chemicals, shows healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Chemicals industry. Institutional ownership is very high, and one analyst has rated it as a Buy with a target price of $75.00.
Stepan Co (SCL) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Stepan Co (SCL), identifying major institutional holders like BlackRock, Hightower Advisors, and Vanguard. It breaks down shareholder types by proportion, showing investment advisors as the largest category. The report also includes historical institutional shareholding data and lists various ETFs that hold SCL stock.
Stepan Company (SCL) Stock Forecasts
Argus has raised its target price for Stepan Company (SCL) to $62.00. The company, which manufactures and sells chemicals and chemical-based products across three segments, currently trades at $58.57. This update comes with an invitation for users to upgrade to premium for more detailed research reports and insights.
Stepan Company (SCL) Stock forecasts
Argus has raised the target price for Stepan Company (SCL) to $60.00, with the stock currently trading at $57.57. Stepan Co. manufactures and sells various chemicals and chemical-based products, organized into three segments. The report providing this information was published on July 15, 2026.
Stepan stock reflects steady specialty chemical growth after mixed 2024 results
Stepan Company reported mixed results for 2024, with net sales declining to $2.0 billion from $2.2 billion in 2023, while profitability and cash generation improved. The specialty chemicals group saw increased adjusted net income and operating margin, supported by a richer product mix, cost discipline, and lower raw material costs. Investors are weighing these results, along with a higher dividend and ongoing capacity investments, as the company emphasizes high-margin surfactants and specialty products in its long-term strategy.
Stepan Company (SCL) Q1 2024 Earnings Report - Results, Call & Slides
Stepan Company (SCL) reported its Q1 2024 earnings, showing an actual EPS of $0.64, beating the consensus estimate of $0.35 by $0.29. However, the company missed revenue expectations, reporting $551.42 million against an expected $575.83 million, marking a 15.35% year-over-year decline. The earnings call took place on April 30, 2024, and the next earnings report is estimated for July 29, 2026.
Stepan to Announce Second Quarter 2026 Results on July 29, 2026
Stepan Company (SCL) will release its second quarter 2026 earnings on Wednesday, July 29, 2026, at approximately 7:00 a.m. ET. The company will host a conference call on the same day at 9:00 a.m. ET to discuss its financial and operational performance, with CEO Luis E. Rojo and CFO Ruben Velasquez. The call will be accessible via phone registration and webcast.
Stepan to Announce Second Quarter 2026 Results on July 29, 2026
Stepan Company (SCL) will release its second quarter 2026 earnings on Wednesday, July 29, 2026, at approximately 7:00 a.m. ET. The company will also host a conference call on the same day at 9:00 a.m. ET to discuss its financial and operational performance, with President and CEO Luis E. Rojo and Vice President and CFO Ruben Velasquez leading the call. Access to the call will be available via phone registration and webcast.
Stepan to Announce Second Quarter 2026 Results on July 29, 2026
Stepan Company (NYSE: SCL) will release its second quarter 2026 earnings results on Wednesday, July 29, 2026, at approximately 7:00 a.m. ET. The company will host a conference call on the same day at 9:00 a.m. ET to discuss its financial and operational performance. Supporting slides and a webcast replay will be available on the company's website.
Is Stepan’s Russell 2000 Dynamic Index Inclusion (SCL) Altering The Investment Case For Investors?
Stepan Company (SCL) was recently added to the Russell 2000 Dynamic Index, increasing its visibility and potential for institutional ownership. While this inclusion may boost liquidity, it doesn't change the immediate need for Stepan to improve its profitability and address Q1 2026 losses. Investors are keenly watching how the company manages raw material costs and maximizes benefits from new investments like Pasadena, especially given the wide range of fair value estimates for the stock.
Stepan lines up July 29 earnings call and results release
Stepan (NYSE: SCL) is scheduled to release its second-quarter 2026 earnings results on July 29, 2026, at approximately 7:00 a.m. ET. The company will also host a conference call and webcast at 9:00 a.m. ET on the same day to discuss its financial and operational performance, led by CEO Luis E. Rojo and CFO Ruben Velasquez. Supporting slides for the earnings call will be available on Stepan's investor relations page.
Stepan Company outlook amid evolving specialty chemicals demand
Stepan Company operates in the specialty chemicals sector, manufacturing surfactants, polymers, and other performance products for a variety of industries including cleaning, personal care, agriculture, and energy. The company
Enterprise value to revenue forward of Stepan Company – NYSE:SCL
This article provides access to the enterprise value to revenue forward financial data for Stepan Company (NYSE: SCL) on TradingView. It appears to be a financial data page rather than a traditional article, offering various financial tools, market data, and community features related to the stock. The content is primarily a platform navigation and data display, indicating where users can find financial statistics for SCL.
Enterprise value to revenue forward of Stepan Co – FWB:96S
This article provides financial information for Stepan Co (FWB:96S) on TradingView, specifically focusing on its enterprise value to revenue forward. It also lists general information about the company provided on the platform, including market data and links to various TradingView features. The content indicates that the market for Stepan Co (FWB:96S) was closed at the time of publication, with no trades recorded.
Price to earnings forward of Stepan Company – NYSE:SCL
This page provides the "Price to earnings forward" value for Stepan Company (NYSE: SCL). The article indicates the market was closed and no trades were made at the time of viewing. It appears to be a financial data snippet from TradingView.
